A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

Study Identifier
GMA-BTXC-12-001
CT.gov Identifier
NCT01777620
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Facial Aesthetics - Fillers
    • Study Drug
  • onabotulinumtoxinA
  • Normal Saline
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18 - 65 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Glabellar lines and crow's feet lines * No prior use of botulinum toxin therapy of any serotype for any reason
    Exclusion Criteria:
    * Previous facial cosmetic surgery, tissue grafting, or tissue augmentation with silicone or fat or other permanent fillers * Planning a facial cosmetic procedure during the study period * Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, and/or amyotrophic lateral sclerosis * Anticipated need for treatment with botulinum toxin of any serotype for any reason during the study (other than study treatment)

    Protocol Summary

    This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).

    Study Locations

    Location
    Status
    Location
    Toronto, Ontario, Canada
    Status
    Not applicable